Crescent Biopharma (CBIO) FCF Margin (2013 - 2026)
Crescent Biopharma (CBIO) reported FCF Margin of 870.74% for Q1 2026, up 95.99% on a QoQ basis from 21695.8% in Q2 2022.
Crescent Biopharma (CBIO) has 8 years of FCF Margin data on file, last reported at 870.74% in Q1 2026.
- Quarterly FCF Margin changed N/A year-over-year to 870.74% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6709.05% (changed N/A YoY) and the FY2025 annual result came in at 659.45%, changed N/A from the prior year.
- FCF Margin advanced to 870.74% in Q1 2026 per CBIO's latest filing, from 21695.8% in the prior quarter.
- Across five years, FCF Margin topped out at 870.74% in Q1 2026 and bottomed at 21695.8% in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.17% |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | -870.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -870.74% |
| Jun 30, 2022 | -21,695.80% |
| Dec 31, 2021 | -72,675.25% |
| Sep 30, 2021 | -19,582.49% |
| Jun 30, 2021 | -9,589,105.63% |
| Mar 31, 2021 | -1,338.62% |
| Dec 31, 2020 | -5,980.21% |
| Sep 30, 2020 | -1,150.00% |
| Mar 31, 2020 | -38.98% |
| Sep 30, 2016 | -40,330.17% |
| Dec 31, 2015 | -19,676.90% |
| Sep 30, 2015 | 38,178.15% |
| Jun 30, 2015 | -31.74% |
| Jun 30, 2014 | 60.77% |
| Dec 31, 2013 | -7,205.59% |
| Sep 30, 2013 | -6,521.65% |
| Jun 30, 2013 | -4,959.27% |
| Mar 31, 2013 | -101.99% |